|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:CYP1A1-FTSJ3 (FusionGDB2 ID:21014) |
Fusion Gene Summary for CYP1A1-FTSJ3 |
Fusion gene summary |
Fusion gene information | Fusion gene name: CYP1A1-FTSJ3 | Fusion gene ID: 21014 | Hgene | Tgene | Gene symbol | CYP1A1 | FTSJ3 | Gene ID | 1543 | 117246 |
Gene name | cytochrome P450 family 1 subfamily A member 1 | FtsJ RNA 2'-O-methyltransferase 3 | |
Synonyms | AHH|AHRR|CP11|CYP1|CYPIA1|P1-450|P450-C|P450DX | EPCS3|SPB1 | |
Cytomap | 15q24.1 | 17q23.3 | |
Type of gene | protein-coding | protein-coding | |
Description | cytochrome P450 1A1aryl hydrocarbon hydroxylasecytochrome P1-450, dioxin-induciblecytochrome P450 form 6cytochrome P450, family 1, subfamily A, polypeptide 1cytochrome P450, subfamily I (aromatic compound-inducible), polypeptide 1cytochrome P450-Cc | pre-rRNA 2'-O-ribose RNA methyltransferase FTSJ32'-O-ribose RNA methyltransferase SPB1 homologFtsJ RNA methyltransferase homolog 3FtsJ homolog 3SPB1 RNA methyltransferase homologpre-rRNA processing protein FTSJ3protein ftsJ homolog 3putative rRNA m | |
Modification date | 20200322 | 20200313 | |
UniProtAcc | . | Q8IY81 | |
Ensembl transtripts involved in fusion gene | ENST00000395048, ENST00000379727, ENST00000567032, ENST00000395049, ENST00000564596, | ENST00000427159, ENST00000580295, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 6 X 4 X 2=48 |
# samples | 1 | 6 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(6/48*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: CYP1A1 [Title/Abstract] AND FTSJ3 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | CYP1A1(75017787)-FTSJ3(61897663), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | CYP1A1 | GO:0002933 | lipid hydroxylation | 14559847 |
Hgene | CYP1A1 | GO:0006631 | fatty acid metabolic process | 15041462 |
Hgene | CYP1A1 | GO:0008202 | steroid metabolic process | 14559847 |
Hgene | CYP1A1 | GO:0008210 | estrogen metabolic process | 11555828|12865317|14559847 |
Hgene | CYP1A1 | GO:0017144 | drug metabolic process | 19219744 |
Hgene | CYP1A1 | GO:0042572 | retinol metabolic process | 10681376 |
Hgene | CYP1A1 | GO:0055114 | oxidation-reduction process | 19219744 |
Hgene | CYP1A1 | GO:0071407 | cellular response to organic cyclic compound | 23275542 |
Tgene | FTSJ3 | GO:0001510 | RNA methylation | 30626973 |
Fusion gene breakpoints across CYP1A1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across FTSJ3 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS5.0 | N/A | DB145273 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
Top |
Fusion Gene ORF analysis for CYP1A1-FTSJ3 |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5UTR-3CDS | ENST00000395048 | ENST00000427159 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
5UTR-intron | ENST00000395048 | ENST00000580295 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
5UTR-3CDS | ENST00000379727 | ENST00000427159 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
5UTR-intron | ENST00000379727 | ENST00000580295 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
intron-3CDS | ENST00000567032 | ENST00000427159 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
intron-intron | ENST00000567032 | ENST00000580295 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
5UTR-3CDS | ENST00000395049 | ENST00000427159 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
5UTR-intron | ENST00000395049 | ENST00000580295 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
5UTR-3CDS | ENST00000564596 | ENST00000427159 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
5UTR-intron | ENST00000564596 | ENST00000580295 | CYP1A1 | chr15 | 75017787 | - | FTSJ3 | chr17 | 61897663 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
Top |
Fusion Genomic Features for CYP1A1-FTSJ3 |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for CYP1A1-FTSJ3 |
Go to FGviewer for the breakpoints of :-: - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | FTSJ3 |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: RNA 2'-O-methyltransferase involved in the processing of the 34S pre-rRNA to 18S rRNA and in 40S ribosomal subunit formation. {ECO:0000255|HAMAP-Rule:MF_03163, ECO:0000269|PubMed:22195017}.; FUNCTION: (Microbial infection) In case of infection by HIV-1 virus, recruited to HIV-1 RNA and catalyzes 2'-O-methylation of the viral genome, allowing HIV-1 virus to escape the innate immune system (PubMed:30626973). RNA 2'-O-methylation provides a molecular signature for discrimination of self from non-self and is used by HIV-1 to evade innate immune recognition by IFIH1/MDA5 (PubMed:30626973). Mediates methylation of internal residues of HIV-1 RNA, with a strong preference for adenosine (PubMed:30626973). Recruited to HIV-1 RNA via interaction with TARBP2/TRBP (PubMed:30626973). {ECO:0000269|PubMed:30626973}. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
Fusion Gene Sequence for CYP1A1-FTSJ3 |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
Top |
Fusion Gene PPI Analysis for CYP1A1-FTSJ3 |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for CYP1A1-FTSJ3 |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for CYP1A1-FTSJ3 |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | CYP1A1 | C0000786 | Spontaneous abortion | 2 | CTD_human |
Hgene | CYP1A1 | C0000822 | Abortion, Tubal | 2 | CTD_human |
Hgene | CYP1A1 | C0020538 | Hypertensive disease | 2 | CTD_human |
Hgene | CYP1A1 | C0033578 | Prostatic Neoplasms | 2 | CTD_human |
Hgene | CYP1A1 | C0162820 | Dermatitis, Allergic Contact | 2 | CTD_human |
Hgene | CYP1A1 | C0273115 | Lung Injury | 2 | CTD_human |
Hgene | CYP1A1 | C0376358 | Malignant neoplasm of prostate | 2 | CTD_human |
Hgene | CYP1A1 | C2350344 | Chronic Lung Injury | 2 | CTD_human |
Hgene | CYP1A1 | C3830362 | Early Pregnancy Loss | 2 | CTD_human |
Hgene | CYP1A1 | C4552766 | Miscarriage | 2 | CTD_human |
Hgene | CYP1A1 | C0002152 | Alloxan Diabetes | 1 | CTD_human |
Hgene | CYP1A1 | C0003860 | Arteritis | 1 | CTD_human |
Hgene | CYP1A1 | C0005612 | Birth Weight | 1 | CTD_human |
Hgene | CYP1A1 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
Hgene | CYP1A1 | C0011609 | Drug Eruptions | 1 | CTD_human |
Hgene | CYP1A1 | C0011616 | Contact Dermatitis | 1 | CTD_human |
Hgene | CYP1A1 | C0011853 | Diabetes Mellitus, Experimental | 1 | CTD_human |
Hgene | CYP1A1 | C0018552 | Hamartoma | 1 | CTD_human |
Hgene | CYP1A1 | C0018800 | Cardiomegaly | 1 | CTD_human |
Hgene | CYP1A1 | C0019209 | Hepatomegaly | 1 | CTD_human |
Hgene | CYP1A1 | C0020517 | Hypersensitivity | 1 | CTD_human |
Hgene | CYP1A1 | C0021364 | Male infertility | 1 | CTD_human |
Hgene | CYP1A1 | C0022665 | Kidney Neoplasm | 1 | CTD_human |
Hgene | CYP1A1 | C0023976 | Long QT Syndrome | 1 | CTD_human |
Hgene | CYP1A1 | C0024117 | Chronic Obstructive Airway Disease | 1 | CTD_human |
Hgene | CYP1A1 | C0028797 | Occupational Diseases | 1 | CTD_human |
Hgene | CYP1A1 | C0038433 | Streptozotocin Diabetes | 1 | CTD_human |
Hgene | CYP1A1 | C0039239 | Sinus Tachycardia | 1 | CTD_human |
Hgene | CYP1A1 | C0085096 | Peripheral Vascular Diseases | 1 | CTD_human |
Hgene | CYP1A1 | C0086132 | Depressive Symptoms | 1 | PSYGENET |
Hgene | CYP1A1 | C0162351 | Contact hypersensitivity | 1 | CTD_human |
Hgene | CYP1A1 | C0242706 | Hyperoxia | 1 | CTD_human |
Hgene | CYP1A1 | C0406537 | Morbilliform Drug Reaction | 1 | CTD_human |
Hgene | CYP1A1 | C0428977 | Bradycardia | 1 | CTD_human |
Hgene | CYP1A1 | C0678222 | Breast Carcinoma | 1 | CTD_human |
Hgene | CYP1A1 | C0740457 | Malignant neoplasm of kidney | 1 | CTD_human |
Hgene | CYP1A1 | C0848676 | Subfertility, Male | 1 | CTD_human |
Hgene | CYP1A1 | C0917731 | Male sterility | 1 | CTD_human |
Hgene | CYP1A1 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
Hgene | CYP1A1 | C1383860 | Cardiac Hypertrophy | 1 | CTD_human |
Hgene | CYP1A1 | C1449861 | Micronuclei, Chromosome-Defective | 1 | CTD_human |
Hgene | CYP1A1 | C1449862 | Micronuclei, Genotoxicant-Induced | 1 | CTD_human |
Hgene | CYP1A1 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
Hgene | CYP1A1 | C1527303 | Chronic Airflow Obstruction | 1 | CTD_human |
Hgene | CYP1A1 | C1527304 | Allergic Reaction | 1 | CTD_human |
Hgene | CYP1A1 | C2239176 | Liver carcinoma | 1 | CTD_human |
Hgene | CYP1A1 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |